Cardiac Insight Inc.
Bellevue, US · 4 known investors
Find your way into Cardiac Insight Inc.
13 people in our graph share verified history with the Cardiac Insight Inc. team — schools, employers, funds. One of them is your warm intro.
Cardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring. The company serves healthcare providers and patients seeking reliable electrocardiogram analysis and cardiac evaluation.
Founders & leadership


Board

Investors · 4
Reported raises · per SEC filings
Form D private placements$35.3M disclosed across 8 rounds · 2014–2022
▶$11.6MraisedMar 2022 · 6 investors · Other Health CareRule 506(b)
- Hyoung Min KimExecutive Officer, Director
- Michael SchuhExecutive Officer
- Robert OdellExecutive Officer
- Ann DemareeExecutive Officer
- David HadleyExecutive Officer
- Daniel TylutkiExecutive Officer
- Stacy SprouseExecutive Officer
- Kurt NoltensmeyerExecutive Officer
- Offering amount
- $12.1M
- Amount sold
- $11.6M
- Minimum investment
- $20K
- First sale
- Mar 2022
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$4.7MraisedAug 2019 · 12 investors · BiotechnologyRule 506(b)
- Richard MartinDirector
- Bob OdellExecutive Officer
- Mike SchuhExecutive Officer
- Brad HarlowExecutive Officer, Director
- Kirby CramerDirector
- Robert deGavreDirector
- Clifford StocksDirector
- Offering amount
- $11.8M
- Amount sold
- $4.7M
- First sale
- Jul 2019
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$2.8MraisedAug 2017 · 31 investors · BiotechnologyRule 506(b)
- Robert deGavreDirector
- Bob OdellExecutive Officer
- Kirby CramerDirector
- Mike SchuhExecutive Officer
- Tom ClementDirector
- Brad HarlowExecutive Officer, Director
- Robert HauserDirector
- Richard MartinDirector
- Lex GambleDirector
- Bill WillisExecutive Officer
- Offering amount
- $10M
- Amount sold
- $2.8M
- First sale
- May 2017
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$1MraisedDec 2016 · 1 investors · BiotechnologyRule 506(b)
- David LinkerExecutive Officer, Director
- Brad HarlowExecutive Officer, Director
- Lex GambleDirector
- Kirby CramerDirector
- Tom ClementDirector
- Bob OdellExecutive Officer
- Bill WillisExecutive Officer
- Mike SchuhExecutive Officer
- Hemanth ReddyDirector
- Robert deGavreDirector
- Richard MartinDirector
- Robert HauserDirector
- Offering amount
- $2.4M
- Amount sold
- $1M
- First sale
- Nov 2016
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$2.5MraisedApr 2016 · 30 investors · BiotechnologyRule 506(b)
- David LinkerExecutive Officer, Director
- Mike SchuhExecutive Officer
- Kirby CramerDirector
- Bob OdellExecutive Officer
- Hemanth ReddyDirector
- Robert deGavreDirector
- Tom ClementDirector
- Richard MartinDirector
- Robert HauserDirector
- Brad HarlowExecutive Officer, Director
- Lex GambleDirector
- Bill WillisExecutive Officer
- Offering amount
- $5M
- Amount sold
- $2.5M
- First sale
- Apr 2016
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$3.5MraisedSep 2015 · 2 investors · BiotechnologyRule 506(b)
- Bill WillisExecutive Officer
- Hemanth ReddyDirector
- Tom ClementDirector
- Brad HarlowExecutive Officer, Director
- Richard MartinDirector
- Robert deGavreExecutive Officer, Director
- David LinkerExecutive Officer, Director
- Lex GambleDirector
- Mike SchuhExecutive Officer
- Bob OdellExecutive Officer
- Robert HauserDirector
- Kirby CramerDirector
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Sep 2015
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$7.1MraisedJul 2014 · 2 investors · BiotechnologyRule 506(b)
- Mike SchuhExecutive Officer
- David LinkerExecutive Officer, Director
- Bob OdellExecutive Officer
- Richard MartinDirector
- Robert deGavreExecutive Officer, Director
- Kirby CramerDirector
- Bill WillisExecutive Officer
- Lex GambleDirector
- Robert HauserDirector
- Tom ClementDirector
- Brad HarlowExecutive Officer, Director
- Offering amount
- $9.1M
- Amount sold
- $7.1M
- First sale
- Jun 2014
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$2MraisedJan 2014 · 1 investors · BiotechnologyRule 506(b)
- Bill WillisExecutive Officer
- Robert deGavreExecutive Officer, Director
- Richard MartinDirector
- Mike SchuhExecutive Officer
- Brad HarlowExecutive Officer, Director
- Robert HauserDirector
- David LinkerExecutive Officer, Director
- Lex GambleDirector
- Kirby CramerDirector
- Tom ClementDirector
- Bob OdellExecutive Officer
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Jan 2014
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapCompanies competing with Cardiac Insight Inc. for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Cardiac Insight Inc. do?
- Cardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring. The company serves healthcare providers and patients seeking reliable electrocardiogram analysis and cardiac evaluation.
- Who founded Cardiac Insight Inc.?
- Cardiac Insight Inc. was founded by David Linker, Dr. Dave Hadley, Dr. Vic Froelicher.
- Who are Cardiac Insight Inc.'s investors?
- Cardiac Insight Inc.'s investors include Cowles Ventures, Keiretsu Forum, SeaChange, The W Fund.
- How much funding has Cardiac Insight Inc. raised?
- Cardiac Insight Inc. has disclosed $35.3M raised across 8 rounds.
- Where is Cardiac Insight Inc. headquartered?
- Cardiac Insight Inc. is headquartered in Bellevue, US.

